Buy Dabur India: IIFL Securities's Target Price Rs 680

IIFL Securities recommends buying Dabur India at the current market price of Rs 659.75, with a target price of Rs 680. The company is expected to benefit from strong demand for its Ayurvedic and FMCG products and a favorable rural environment. Dabur's consistent growth in market share and focus on innovation are seen as positive factors, driving analysts' optimism about the stock's performance in the near term.

About Dabur India:

Dabur India Limited is a leading Indian consumer goods company, headquartered in Ghaziabad, India. Founded in 1884, Dabur is one of the oldest and most trusted consumer goods companies in India. The company manufactures and markets a wide range of healthcare and personal care products, including ayurvedic medicines, home care products, and personal care products. Dabur is known for its popular brands such as Dabur Chyawanprash, Vatika, and Hajmola. The company has a global presence with operations in over 100 countries.

52 Week Price Trend:

Dabur India, a leading FMCG company in India, is currently trading at Rs 659.75, recording gains over the past 52 weeks. The 52-week high price for Dabur was Rs 597.1, while the low price stood at Rs 503.65. This indicates a positive trend in the stock's performance, suggesting that the company has been able to maintain its market position and grow its business amidst challenging market conditions. Analysts remain optimistic about Dabur's future prospects, citing its strong brand portfolio, distribution network, and focus on innovation.

Stratzy's MOST Analysis:

DABUR has been rated BBB by Stratzy's MOST framework, which assesses a stock's fundamentals across four pillars: Management, Outlook, Safety, and Trend. This BBB rating indicates that DABUR has medium fundamental risks. The management team is considered competent and the company has a stable outlook. DABUR's financial position is sound, with strong cash flows and low debt levels. The industry trend is also favorable, with growing demand for Ayurvedic and herbal products.

Company's Fundamentals:

Dabur India (NSE: DABUR) is an Indian consumer goods company with a diverse portfolio of Ayurvedic medicines, personal care products, and food and beverage items. As of today, DABUR stock trades at a Price-to-Earnings (PE) ratio of 53.2, indicating that investors are willing to pay 53.2 times the company's annual earnings per share. The Price-to-Book (PB) ratio of 9.89 implies that the market value of DABUR's assets is 9.89 times its book value. Lastly, the Dividend Yield of 0.98% represents the annual dividend income received per share as a percentage of the current stock price. These metrics help investors evaluate the company's valuation, profitability, and income-generating capacity.

Fundamental and Technical information provided in this blog were last updated on 07 Sep, 2024

Disclaimer: The information and recommendations presented in this section, including any attached reports, are sourced from third-party providers through diverse channels. The views and opinions expressed within these materials belong solely to their respective creators. These views and opinions do not necessarily reflect the position of Stratzy Fintech Pvt Ltd. Stratzy explicitly disclaims any guarantees, express or implied, regarding the accuracy and reliability of the provided content. We strongly advise consulting with a licensed financial advisor before making any investment decisions based on this information. Remember, seeking independent financial advice is crucial.